pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
396
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
MVREX-107
Pulmonary Fibrosis
Immvira Co Ltd
0
catalysts
Phase 2
MesenCure
Acute Respiratory Distress Syndrome
Bonus BioGroup Ltd
0
catalysts
pre_registration
N-115
Chronic Obstructive Pulmonary Disease (COPD)
EmphyCorp Inc
0
catalysts
Phase 1
NAS-150
Idiopathic Pulmonary Fibrosis
← prev
page 7 of 14
next →
131
Pain
89
Neurology
1
New Amsterdam Sciences Inc
0
catalysts
Preclinical
NCEs
Unspecified Respiratory Disorders
Chiesi USA Inc
0
catalysts
Preclinical
OCF-203
Idiopathic Pulmonary Fibrosis
$OCEA
Ocean Biomedical, Inc.
0
catalysts
Phase 2
Organ Dysfunction/Mortality
Unspecified
BioAegis Therapeutics Inc
0
catalysts
Preclinical
P-1155
Chronic Obstructive Pulmonary Disease (COPD)
Parion Sciences Inc
0
catalysts
Phase 1
PF-07832837
Atopic Dermatitis (Atopic Eczema)
$PFE
PFIZER INC
0
catalysts
Phase 2
PF-07872412
Streptococcal Pneumonia
$PFE
PFIZER INC
0
catalysts
Phase 2
Panaecin
Panaecintm (gallium citrate)
Chronic Lung Infection
Aridis Pharmaceuticals Inc
0
catalysts
Preclinical
Peptide Derivative
Acute Respiratory Distress Syndrome
PharmaIN Corp
0
catalysts
Phase 2
Pneumostem
Bronchopulmonary Dysplasia
MediPost Co Ltd
0
catalysts
Preclinical
Polymer Lung Surfactant
Acute Respiratory Distress Syndrome
Spirrow Therapeutics LLC
0
catalysts
Phase 1
QX-027N
Chronic Obstructive Pulmonary Disease (COPD)
Windward Bio AG
0
catalysts
Preclinical
QX-031N
Unspecified Respiratory Disorders
F. Hoffmann-La Roche Ltd
0
catalysts
Preclinical
QX-035N
Unspecified Respiratory Disorders
JiangSu Qyuns Therapeutics Co Ltd
0
catalysts
Marketed
Qvar Redihaler
Qvar Redihaler (beclomethasone dipropionate)
Asthma
Teva Respiratory LLC
0
catalysts
Phase 1
RCT-1100
Primary Ciliary Dyskinesia
Recode Therapeutics Inc
0
catalysts
Phase 2
RCT-2100
Cystic Fibrosis
Recode Therapeutics Inc
0
catalysts
Phase 1
REX-8756
Asthma
Recludix Pharma Inc
0
catalysts
Preclinical
RFT-1124
Post-Operative Pain
RAFT Pharmaceuticals LLC
0
catalysts
Preclinical
RSBT-001
Coronavirus Disease 2019 (COVID-19)
RS BioTherapeutics Inc
0
catalysts
Phase 2
SASS-001
Obstructive Sleep Apnea
Shionogi-Apnimed Sleep Science LLC
0
catalysts
Preclinical
SBC-101
Idiopathic Pulmonary Fibrosis
Sapiens Bio Co Ltd
0
catalysts
Preclinical
SG-001
Streptococcal Pneumonia
$ADMA
ADMA BIOLOGICS, INC.
0
catalysts
Phase 1
SION-109
Cystic Fibrosis
$SION
Sionna Therapeutics, Inc.
0
catalysts
Phase 2
SION-719
Cystic Fibrosis
$SION
Sionna Therapeutics, Inc.
0
catalysts
Phase 2
SP-101
Cystic Fibrosis
Spirovant Sciences Inc
0
catalysts
Preclinical
SPL-23
Cystic Fibrosis
SpliSense Ltd
0
catalysts
